---
title: "Shire Pharmaceuticals International Unlimited Company — Ownership Dossier"
canonical: https://whiteintel.dev/entity/702f91e2-4305-46df-882e-2eb16208f7b3
json: https://whiteintel.dev/api/public/dossier/702f91e2-4305-46df-882e-2eb16208f7b3
identifier: gb-coh:534668
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# Shire Pharmaceuticals International Unlimited Company

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `gb-coh:534668`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/702f91e2-4305-46df-882e-2eb16208f7b3  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/702f91e2-4305-46df-882e-2eb16208f7b3  

## Ownership & control

### Holdings / subsidiaries

- **Takeda Pharmaceutical Company Limited** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/c6d66986-6ed3-5e51-9314-2bfb98437f5f

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **Shire Pharmaceuticals International Unlimited Company**. Human view: https://whiteintel.dev/entity/702f91e2-4305-46df-882e-2eb16208f7b3 · Structured JSON: https://whiteintel.dev/api/public/dossier/702f91e2-4305-46df-882e-2eb16208f7b3._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._